Cybille Delacroix Muirhei

Array ( [id] => 4013221 [patent_doc_number] => 05962642 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Method for sequencing of protein or peptide' [patent_app_type] => 1 [patent_app_number] => 8/854187 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3109 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962642.pdf [firstpage_image] =>[orig_patent_app_number] => 854187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013057 [patent_doc_number] => 05962634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'IgE antagonists' [patent_app_type] => 1 [patent_app_number] => 8/765536 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11327 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962634.pdf [firstpage_image] =>[orig_patent_app_number] => 765536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946543 [patent_doc_number] => 05990283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Proteins catalyzing the extension of plant cell walls' [patent_app_type] => 1 [patent_app_number] => 8/834327 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 34 [patent_no_of_words] => 15670 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990283.pdf [firstpage_image] =>[orig_patent_app_number] => 834327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024332 [patent_doc_number] => 05925730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'GnRH antagonists' [patent_app_type] => 1 [patent_app_number] => 8/837042 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14181 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925730.pdf [firstpage_image] =>[orig_patent_app_number] => 837042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349634 [patent_doc_number] => 06214796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Administration of polypeptide growth factors following central nervous system ischemia or trauma' [patent_app_type] => 1 [patent_app_number] => 8/822455 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 8492 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214796.pdf [firstpage_image] =>[orig_patent_app_number] => 822455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470124 [patent_doc_number] => 06407060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Method for enhancing functional recovery following central nervous system ischemia or trauma' [patent_app_type] => B1 [patent_app_number] => 08/828281 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19639 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407060.pdf [firstpage_image] =>[orig_patent_app_number] => 08828281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022620 [patent_doc_number] => 05925620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Therapeutically active mixture of glutathione and anthocyanin compounds' [patent_app_type] => 1 [patent_app_number] => 8/815552 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2130 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925620.pdf [firstpage_image] =>[orig_patent_app_number] => 815552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058079 [patent_doc_number] => 05863901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders' [patent_app_type] => 1 [patent_app_number] => 8/810012 [patent_app_country] => US [patent_app_date] => 1997-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6692 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863901.pdf [firstpage_image] =>[orig_patent_app_number] => 810012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4200904 [patent_doc_number] => 06013773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Pharmaceutical preparation containing human growth hormone' [patent_app_type] => 1 [patent_app_number] => 8/791728 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6684 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013773.pdf [firstpage_image] =>[orig_patent_app_number] => 791728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3778982 [patent_doc_number] => 05808256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method of controlling a photoreaction with a laser beam' [patent_app_type] => 1 [patent_app_number] => 8/787087 [patent_app_country] => US [patent_app_date] => 1997-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 3295 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808256.pdf [firstpage_image] =>[orig_patent_app_number] => 787087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979707 [patent_doc_number] => 05948764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein' [patent_app_type] => 1 [patent_app_number] => 8/781122 [patent_app_country] => US [patent_app_date] => 1997-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 20 [patent_no_of_words] => 10525 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948764.pdf [firstpage_image] =>[orig_patent_app_number] => 781122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408510 [patent_doc_number] => 06239099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Methods of treating viral infections' [patent_app_type] => 1 [patent_app_number] => 8/767795 [patent_app_country] => US [patent_app_date] => 1996-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14612 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239099.pdf [firstpage_image] =>[orig_patent_app_number] => 767795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249527 [patent_doc_number] => 06221893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Administration of histamine for therapeutic purposes' [patent_app_type] => 1 [patent_app_number] => 8/767338 [patent_app_country] => US [patent_app_date] => 1996-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10010 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221893.pdf [firstpage_image] =>[orig_patent_app_number] => 767338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805566 [patent_doc_number] => 05830863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Neurokinin A antagonists' [patent_app_type] => 1 [patent_app_number] => 8/764157 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11967 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830863.pdf [firstpage_image] =>[orig_patent_app_number] => 764157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838416 [patent_doc_number] => 05744363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Method for establishing a tumor-cell line by preparing single-cell suspension of tumor cells from tumor biopsies' [patent_app_type] => 1 [patent_app_number] => 8/764571 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4317 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744363.pdf [firstpage_image] =>[orig_patent_app_number] => 764571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183889 [patent_doc_number] => 06150330 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Aqueous prolonged release formulation' [patent_app_type] => 1 [patent_app_number] => 8/766563 [patent_app_country] => US [patent_app_date] => 1996-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3610 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150330.pdf [firstpage_image] =>[orig_patent_app_number] => 766563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4223329 [patent_doc_number] => 06011015 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Angiotensin II for improving fertilization' [patent_app_type] => 1 [patent_app_number] => 8/750316 [patent_app_country] => US [patent_app_date] => 1996-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 1807 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011015.pdf [firstpage_image] =>[orig_patent_app_number] => 750316 [rel_patent_id] =>[rel_patent_doc_number] =>)